RedHill Biopharma Ltd. (RDHL)

RedHill Biopharma Revenue

RedHill Biopharma had revenue of $4.08M in the half year ending June 30, 2025, a decrease of -24.39%. This brings the company's revenue in the last twelve months to $9.55M, up 157.62% year-over-year. In the year 2024, RedHill Biopharma had annual revenue of $8.04M with 23.17% growth.

• Revenue (ttm): $9.55M
• Revenue Growth: +157.62%
• P/S Ratio: 0.23
• Revenue / Employee: $272,857
• Employees: 35
• Market Cap: 3.29M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.04M	1.51M	23.17%
Dec 31, 2023	6.53M	-55.27M	-89.43%
Dec 31, 2022	61.80M	-23.96M	-27.94%
Dec 31, 2021	85.76M	21.40M	33.25%
Dec 31, 2020	64.36M	58.07M	923.03%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.